IMFINZI (Durvalumab) 120 mg Injection
IMFINZI Durvalumab 120 mg Injection is an advanced immunotherapy medicine used in oncology for the treatment of several types of cancers. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) blocking antibody that helps the immune system recognize and destroy cancer cells. It is mainly used in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and biliary tract cancers, often as maintenance therapy after chemotherapy or radiotherapy.
This medicine is part of immune checkpoint inhibitor therapy, which strengthens the body’s natural defense system against cancer.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 120 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 protein on cancer cells
- Reactivating immune T-cell response
- Enhancing body’s ability to detect tumors
- Slowing or stopping cancer progression
Uses and Treatments
IMFINZI (Durvalumab) 120 mg Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation
Dosage and How to Use
- Administered as intravenous infusion only in hospital settings
- Given every 2–4 weeks depending on treatment plan
- Dosage is decided by oncologist based on patient condition
- Must be used strictly under medical supervision
Advantages of IMFINZI (Durvalumab)
- Strengthens immune response against cancer
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy with precise mechanism
- Helps delay cancer progression and recurrence
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- For hospital/oncology use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so no direct Indian generic version exists. However, similar immune checkpoint inhibitors include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and cancer supportive therapies from Dr. Reddy’s Laboratories
All alternatives must be selected only under oncologist supervision.
Buy IMFINZI Durvalumab 120 mg Injection Online in India – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 120 mg Injection in India? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure delivery across India.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical quality standards and reliable global logistics support.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply chain
- Expert support for hospital procurement
- Buy Durvalumab 120 mg India
- IMFINZI injection price India
- Lung cancer immunotherapy India
- PD-L1 inhibitor medicine India
- Cancer immunotherapy injection India
- Oncology medicine exporter India
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across India!
